California 2023-2024 Regular Session

California Assembly Bill AB632 Compare Versions

OldNewDifferences
1-Enrolled September 11, 2023 Passed IN Senate September 06, 2023 Passed IN Assembly September 07, 2023 Amended IN Senate June 15, 2023 CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION Assembly Bill No. 632Introduced by Assembly Member GipsonFebruary 09, 2023 An act to amend Section 1367.64 of the Health and Safety Code, and to amend Section 10123.835 of the Insurance Code, relating to health care coverage. LEGISLATIVE COUNSEL'S DIGESTAB 632, Gipson. Health care coverage: prostate cancer screening.Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires an individual and group health care service plan contract or health insurance policy to provide coverage for the screening and diagnosis of prostate cancer when medically necessary and consistent with good professional practice. Under existing law, the application of a deductible or copayment for those services is not prohibited.This bill would instead require that coverage when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines. The bill would prohibit a health care service plan or a health insurance policy issued, amended, renewed, or delivered on or after January 1, 2024, from applying a deductible, copayment, or coinsurance to coverage for prostate cancer screening services for an enrollee or insured who is at a high risk of prostate cancer, consistent with specified guidelines, and is either 55 years of age or older or 40 years of age or older and high risk, as determined by the attending or treating health care provider. Because a willful violation of these provisions by a health care service plan would be a crime, the bill would impose a state-mandated local program.The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.This bill would provide that no reimbursement is required by this act for a specified reason.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: YES Bill TextThe people of the State of California do enact as follows:SECTION 1. Section 1367.64 of the Health and Safety Code is amended to read:1367.64. (a) Every individual or group health care service plan contract, except for a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines.(b) This section does not establish a new mandated benefit or to prevent application of deductible or copayment provisions in a policy or plan, nor does this section require that a policy or plan be extended to cover any other procedures under a health care service plan contract. This section does not authorize an enrollee to receive the services required to be covered by this section if those services are furnished by a nonparticipating provider, unless the enrollee is referred to that provider by a participating physician or nurse practitioner providing care.(c) (1) Notwithstanding subdivision (b), a health care service plan contract, except a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an enrollee who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.SEC. 2. Section 10123.835 of the Insurance Code is amended to read:10123.835. (a) A health insurance policy that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines.(b) This section does not require a health insurance policy to cover the surgical and other procedures known as radical prostatectomy, external beam radiation therapy, radiation seed implants, and combined hormonal therapy, or to prevent application of deductible or copayment provisions contained in the policy, nor does this section require that coverage under a health insurance policy be extended to any other procedures.(c) (1) Notwithstanding subdivision (b), a health insurance policy that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an insured who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.(d) This section does not apply to specialized health insurance, specified accident, specified disease, hospital indemnity, Medicare supplement, or long-term care health insurance policies.SEC. 3. No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
1+Amended IN Senate June 15, 2023 CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION Assembly Bill No. 632Introduced by Assembly Member GipsonFebruary 09, 2023 An act to amend Section 1367.64 of the Health and Safety Code, and to amend Section 10123.835 of the Insurance Code, relating to health care coverage. LEGISLATIVE COUNSEL'S DIGESTAB 632, as amended, Gipson. Health care coverage: prostate cancer screening.Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires an individual and group health care service plan contract or health insurance policy to provide coverage for the screening and diagnosis of prostate cancer when medically necessary and consistent with good professional practice. Under existing law, the application of a deductible or copayment for those services is not prohibited.This bill would instead require that coverage when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines. The bill would prohibit a health care service plan or a health insurance policy issued, amended, renewed, or delivered on or after January 1, 2024, from applying a deductible, copayment, or coinsurance to coverage for prostate cancer screening services for an enrollee or insured who is at a high risk of prostate cancer, consistent with specified guidelines and is either 55 years of age or older or who is 40 years of age or older and is high risk, as determined by the attending or treating health care provider. Because a willful violation of these provisions by a health care service plan would be a crime, the bill would impose a state-mandated local program.The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.This bill would provide that no reimbursement is required by this act for a specified reason.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: YES Bill TextThe people of the State of California do enact as follows:SECTION 1. Section 1367.64 of the Health and Safety Code is amended to read:1367.64. (a) Every individual or group health care service plan contract, except for a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with good professional practice. nationally recognized, evidence-based clinical guidelines.(b) This section does not establish a new mandated benefit or to prevent application of deductible or copayment provisions in a policy or plan, nor does this section require that a policy or plan be extended to cover any other procedures under a health care service plan contract. This section does not authorize an enrollee to receive the services required to be covered by this section if those services are furnished by a nonparticipating provider, unless the enrollee is referred to that provider by a participating physician or nurse practitioner providing care.(c) (1) Notwithstanding subdivision (b), a health care service plan contract, except a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an enrollee who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. High For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.SEC. 2. Section 10123.835 of the Insurance Code is amended to read:10123.835. (a) A health insurance policy that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with good professional practice. nationally recognized, evidence-based clinical guidelines.(b) This section does not require a health insurance policy to cover the surgical and other procedures known as radical prostatectomy, external beam radiation therapy, radiation seed implants, and combined hormonal therapy, or to prevent application of deductible or copayment provisions contained in the policy, nor does this section require that coverage under a health insurance policy be extended to any other procedures.(c) (1) Notwithstanding subdivision (b), a health insurance policy that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an insured who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. High For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.(d) This section does not apply to specialized health insurance, specified accident, specified disease, hospital indemnity, Medicare supplement, or long-term care health insurance policies.SEC. 3. No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
22
3- Enrolled September 11, 2023 Passed IN Senate September 06, 2023 Passed IN Assembly September 07, 2023 Amended IN Senate June 15, 2023 CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION Assembly Bill No. 632Introduced by Assembly Member GipsonFebruary 09, 2023 An act to amend Section 1367.64 of the Health and Safety Code, and to amend Section 10123.835 of the Insurance Code, relating to health care coverage. LEGISLATIVE COUNSEL'S DIGESTAB 632, Gipson. Health care coverage: prostate cancer screening.Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires an individual and group health care service plan contract or health insurance policy to provide coverage for the screening and diagnosis of prostate cancer when medically necessary and consistent with good professional practice. Under existing law, the application of a deductible or copayment for those services is not prohibited.This bill would instead require that coverage when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines. The bill would prohibit a health care service plan or a health insurance policy issued, amended, renewed, or delivered on or after January 1, 2024, from applying a deductible, copayment, or coinsurance to coverage for prostate cancer screening services for an enrollee or insured who is at a high risk of prostate cancer, consistent with specified guidelines, and is either 55 years of age or older or 40 years of age or older and high risk, as determined by the attending or treating health care provider. Because a willful violation of these provisions by a health care service plan would be a crime, the bill would impose a state-mandated local program.The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.This bill would provide that no reimbursement is required by this act for a specified reason.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: YES
3+ Amended IN Senate June 15, 2023 CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION Assembly Bill No. 632Introduced by Assembly Member GipsonFebruary 09, 2023 An act to amend Section 1367.64 of the Health and Safety Code, and to amend Section 10123.835 of the Insurance Code, relating to health care coverage. LEGISLATIVE COUNSEL'S DIGESTAB 632, as amended, Gipson. Health care coverage: prostate cancer screening.Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires an individual and group health care service plan contract or health insurance policy to provide coverage for the screening and diagnosis of prostate cancer when medically necessary and consistent with good professional practice. Under existing law, the application of a deductible or copayment for those services is not prohibited.This bill would instead require that coverage when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines. The bill would prohibit a health care service plan or a health insurance policy issued, amended, renewed, or delivered on or after January 1, 2024, from applying a deductible, copayment, or coinsurance to coverage for prostate cancer screening services for an enrollee or insured who is at a high risk of prostate cancer, consistent with specified guidelines and is either 55 years of age or older or who is 40 years of age or older and is high risk, as determined by the attending or treating health care provider. Because a willful violation of these provisions by a health care service plan would be a crime, the bill would impose a state-mandated local program.The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.This bill would provide that no reimbursement is required by this act for a specified reason.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: YES
44
5- Enrolled September 11, 2023 Passed IN Senate September 06, 2023 Passed IN Assembly September 07, 2023 Amended IN Senate June 15, 2023
5+ Amended IN Senate June 15, 2023
66
7-Enrolled September 11, 2023
8-Passed IN Senate September 06, 2023
9-Passed IN Assembly September 07, 2023
107 Amended IN Senate June 15, 2023
118
129 CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION
1310
1411 Assembly Bill
1512
1613 No. 632
1714
1815 Introduced by Assembly Member GipsonFebruary 09, 2023
1916
2017 Introduced by Assembly Member Gipson
2118 February 09, 2023
2219
2320 An act to amend Section 1367.64 of the Health and Safety Code, and to amend Section 10123.835 of the Insurance Code, relating to health care coverage.
2421
2522 LEGISLATIVE COUNSEL'S DIGEST
2623
2724 ## LEGISLATIVE COUNSEL'S DIGEST
2825
29-AB 632, Gipson. Health care coverage: prostate cancer screening.
26+AB 632, as amended, Gipson. Health care coverage: prostate cancer screening.
3027
31-Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires an individual and group health care service plan contract or health insurance policy to provide coverage for the screening and diagnosis of prostate cancer when medically necessary and consistent with good professional practice. Under existing law, the application of a deductible or copayment for those services is not prohibited.This bill would instead require that coverage when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines. The bill would prohibit a health care service plan or a health insurance policy issued, amended, renewed, or delivered on or after January 1, 2024, from applying a deductible, copayment, or coinsurance to coverage for prostate cancer screening services for an enrollee or insured who is at a high risk of prostate cancer, consistent with specified guidelines, and is either 55 years of age or older or 40 years of age or older and high risk, as determined by the attending or treating health care provider. Because a willful violation of these provisions by a health care service plan would be a crime, the bill would impose a state-mandated local program.The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.This bill would provide that no reimbursement is required by this act for a specified reason.
28+Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires an individual and group health care service plan contract or health insurance policy to provide coverage for the screening and diagnosis of prostate cancer when medically necessary and consistent with good professional practice. Under existing law, the application of a deductible or copayment for those services is not prohibited.This bill would instead require that coverage when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines. The bill would prohibit a health care service plan or a health insurance policy issued, amended, renewed, or delivered on or after January 1, 2024, from applying a deductible, copayment, or coinsurance to coverage for prostate cancer screening services for an enrollee or insured who is at a high risk of prostate cancer, consistent with specified guidelines and is either 55 years of age or older or who is 40 years of age or older and is high risk, as determined by the attending or treating health care provider. Because a willful violation of these provisions by a health care service plan would be a crime, the bill would impose a state-mandated local program.The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.This bill would provide that no reimbursement is required by this act for a specified reason.
3229
3330 Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires an individual and group health care service plan contract or health insurance policy to provide coverage for the screening and diagnosis of prostate cancer when medically necessary and consistent with good professional practice. Under existing law, the application of a deductible or copayment for those services is not prohibited.
3431
35-This bill would instead require that coverage when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines. The bill would prohibit a health care service plan or a health insurance policy issued, amended, renewed, or delivered on or after January 1, 2024, from applying a deductible, copayment, or coinsurance to coverage for prostate cancer screening services for an enrollee or insured who is at a high risk of prostate cancer, consistent with specified guidelines, and is either 55 years of age or older or 40 years of age or older and high risk, as determined by the attending or treating health care provider. Because a willful violation of these provisions by a health care service plan would be a crime, the bill would impose a state-mandated local program.
32+This bill would instead require that coverage when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines. The bill would prohibit a health care service plan or a health insurance policy issued, amended, renewed, or delivered on or after January 1, 2024, from applying a deductible, copayment, or coinsurance to coverage for prostate cancer screening services for an enrollee or insured who is at a high risk of prostate cancer, consistent with specified guidelines and is either 55 years of age or older or who is 40 years of age or older and is high risk, as determined by the attending or treating health care provider. Because a willful violation of these provisions by a health care service plan would be a crime, the bill would impose a state-mandated local program.
3633
3734 The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
3835
3936 This bill would provide that no reimbursement is required by this act for a specified reason.
4037
4138 ## Digest Key
4239
4340 ## Bill Text
4441
45-The people of the State of California do enact as follows:SECTION 1. Section 1367.64 of the Health and Safety Code is amended to read:1367.64. (a) Every individual or group health care service plan contract, except for a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines.(b) This section does not establish a new mandated benefit or to prevent application of deductible or copayment provisions in a policy or plan, nor does this section require that a policy or plan be extended to cover any other procedures under a health care service plan contract. This section does not authorize an enrollee to receive the services required to be covered by this section if those services are furnished by a nonparticipating provider, unless the enrollee is referred to that provider by a participating physician or nurse practitioner providing care.(c) (1) Notwithstanding subdivision (b), a health care service plan contract, except a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an enrollee who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.SEC. 2. Section 10123.835 of the Insurance Code is amended to read:10123.835. (a) A health insurance policy that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines.(b) This section does not require a health insurance policy to cover the surgical and other procedures known as radical prostatectomy, external beam radiation therapy, radiation seed implants, and combined hormonal therapy, or to prevent application of deductible or copayment provisions contained in the policy, nor does this section require that coverage under a health insurance policy be extended to any other procedures.(c) (1) Notwithstanding subdivision (b), a health insurance policy that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an insured who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.(d) This section does not apply to specialized health insurance, specified accident, specified disease, hospital indemnity, Medicare supplement, or long-term care health insurance policies.SEC. 3. No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
42+The people of the State of California do enact as follows:SECTION 1. Section 1367.64 of the Health and Safety Code is amended to read:1367.64. (a) Every individual or group health care service plan contract, except for a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with good professional practice. nationally recognized, evidence-based clinical guidelines.(b) This section does not establish a new mandated benefit or to prevent application of deductible or copayment provisions in a policy or plan, nor does this section require that a policy or plan be extended to cover any other procedures under a health care service plan contract. This section does not authorize an enrollee to receive the services required to be covered by this section if those services are furnished by a nonparticipating provider, unless the enrollee is referred to that provider by a participating physician or nurse practitioner providing care.(c) (1) Notwithstanding subdivision (b), a health care service plan contract, except a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an enrollee who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. High For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.SEC. 2. Section 10123.835 of the Insurance Code is amended to read:10123.835. (a) A health insurance policy that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with good professional practice. nationally recognized, evidence-based clinical guidelines.(b) This section does not require a health insurance policy to cover the surgical and other procedures known as radical prostatectomy, external beam radiation therapy, radiation seed implants, and combined hormonal therapy, or to prevent application of deductible or copayment provisions contained in the policy, nor does this section require that coverage under a health insurance policy be extended to any other procedures.(c) (1) Notwithstanding subdivision (b), a health insurance policy that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an insured who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. High For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.(d) This section does not apply to specialized health insurance, specified accident, specified disease, hospital indemnity, Medicare supplement, or long-term care health insurance policies.SEC. 3. No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
4643
4744 The people of the State of California do enact as follows:
4845
4946 ## The people of the State of California do enact as follows:
5047
51-SECTION 1. Section 1367.64 of the Health and Safety Code is amended to read:1367.64. (a) Every individual or group health care service plan contract, except for a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines.(b) This section does not establish a new mandated benefit or to prevent application of deductible or copayment provisions in a policy or plan, nor does this section require that a policy or plan be extended to cover any other procedures under a health care service plan contract. This section does not authorize an enrollee to receive the services required to be covered by this section if those services are furnished by a nonparticipating provider, unless the enrollee is referred to that provider by a participating physician or nurse practitioner providing care.(c) (1) Notwithstanding subdivision (b), a health care service plan contract, except a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an enrollee who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.
48+SECTION 1. Section 1367.64 of the Health and Safety Code is amended to read:1367.64. (a) Every individual or group health care service plan contract, except for a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with good professional practice. nationally recognized, evidence-based clinical guidelines.(b) This section does not establish a new mandated benefit or to prevent application of deductible or copayment provisions in a policy or plan, nor does this section require that a policy or plan be extended to cover any other procedures under a health care service plan contract. This section does not authorize an enrollee to receive the services required to be covered by this section if those services are furnished by a nonparticipating provider, unless the enrollee is referred to that provider by a participating physician or nurse practitioner providing care.(c) (1) Notwithstanding subdivision (b), a health care service plan contract, except a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an enrollee who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. High For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.
5249
5350 SECTION 1. Section 1367.64 of the Health and Safety Code is amended to read:
5451
5552 ### SECTION 1.
5653
57-1367.64. (a) Every individual or group health care service plan contract, except for a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines.(b) This section does not establish a new mandated benefit or to prevent application of deductible or copayment provisions in a policy or plan, nor does this section require that a policy or plan be extended to cover any other procedures under a health care service plan contract. This section does not authorize an enrollee to receive the services required to be covered by this section if those services are furnished by a nonparticipating provider, unless the enrollee is referred to that provider by a participating physician or nurse practitioner providing care.(c) (1) Notwithstanding subdivision (b), a health care service plan contract, except a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an enrollee who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.
54+1367.64. (a) Every individual or group health care service plan contract, except for a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with good professional practice. nationally recognized, evidence-based clinical guidelines.(b) This section does not establish a new mandated benefit or to prevent application of deductible or copayment provisions in a policy or plan, nor does this section require that a policy or plan be extended to cover any other procedures under a health care service plan contract. This section does not authorize an enrollee to receive the services required to be covered by this section if those services are furnished by a nonparticipating provider, unless the enrollee is referred to that provider by a participating physician or nurse practitioner providing care.(c) (1) Notwithstanding subdivision (b), a health care service plan contract, except a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an enrollee who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. High For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.
5855
59-1367.64. (a) Every individual or group health care service plan contract, except for a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines.(b) This section does not establish a new mandated benefit or to prevent application of deductible or copayment provisions in a policy or plan, nor does this section require that a policy or plan be extended to cover any other procedures under a health care service plan contract. This section does not authorize an enrollee to receive the services required to be covered by this section if those services are furnished by a nonparticipating provider, unless the enrollee is referred to that provider by a participating physician or nurse practitioner providing care.(c) (1) Notwithstanding subdivision (b), a health care service plan contract, except a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an enrollee who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.
56+1367.64. (a) Every individual or group health care service plan contract, except for a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with good professional practice. nationally recognized, evidence-based clinical guidelines.(b) This section does not establish a new mandated benefit or to prevent application of deductible or copayment provisions in a policy or plan, nor does this section require that a policy or plan be extended to cover any other procedures under a health care service plan contract. This section does not authorize an enrollee to receive the services required to be covered by this section if those services are furnished by a nonparticipating provider, unless the enrollee is referred to that provider by a participating physician or nurse practitioner providing care.(c) (1) Notwithstanding subdivision (b), a health care service plan contract, except a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an enrollee who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. High For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.
6057
61-1367.64. (a) Every individual or group health care service plan contract, except for a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines.(b) This section does not establish a new mandated benefit or to prevent application of deductible or copayment provisions in a policy or plan, nor does this section require that a policy or plan be extended to cover any other procedures under a health care service plan contract. This section does not authorize an enrollee to receive the services required to be covered by this section if those services are furnished by a nonparticipating provider, unless the enrollee is referred to that provider by a participating physician or nurse practitioner providing care.(c) (1) Notwithstanding subdivision (b), a health care service plan contract, except a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an enrollee who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.
58+1367.64. (a) Every individual or group health care service plan contract, except for a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with good professional practice. nationally recognized, evidence-based clinical guidelines.(b) This section does not establish a new mandated benefit or to prevent application of deductible or copayment provisions in a policy or plan, nor does this section require that a policy or plan be extended to cover any other procedures under a health care service plan contract. This section does not authorize an enrollee to receive the services required to be covered by this section if those services are furnished by a nonparticipating provider, unless the enrollee is referred to that provider by a participating physician or nurse practitioner providing care.(c) (1) Notwithstanding subdivision (b), a health care service plan contract, except a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an enrollee who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. High For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.
6259
6360
6461
65-1367.64. (a) Every individual or group health care service plan contract, except for a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines.
62+1367.64. (a) Every individual or group health care service plan contract, except for a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with good professional practice. nationally recognized, evidence-based clinical guidelines.
6663
6764 (b) This section does not establish a new mandated benefit or to prevent application of deductible or copayment provisions in a policy or plan, nor does this section require that a policy or plan be extended to cover any other procedures under a health care service plan contract. This section does not authorize an enrollee to receive the services required to be covered by this section if those services are furnished by a nonparticipating provider, unless the enrollee is referred to that provider by a participating physician or nurse practitioner providing care.
6865
6966 (c) (1) Notwithstanding subdivision (b), a health care service plan contract, except a specialized health care service plan contract, that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an enrollee who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:
7067
7168 (A) A person with a prostate who is 55 years of age or older.
7269
73-(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.
70+(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. High For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.
7471
7572 (2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.
7673
77-SEC. 2. Section 10123.835 of the Insurance Code is amended to read:10123.835. (a) A health insurance policy that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines.(b) This section does not require a health insurance policy to cover the surgical and other procedures known as radical prostatectomy, external beam radiation therapy, radiation seed implants, and combined hormonal therapy, or to prevent application of deductible or copayment provisions contained in the policy, nor does this section require that coverage under a health insurance policy be extended to any other procedures.(c) (1) Notwithstanding subdivision (b), a health insurance policy that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an insured who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.(d) This section does not apply to specialized health insurance, specified accident, specified disease, hospital indemnity, Medicare supplement, or long-term care health insurance policies.
74+SEC. 2. Section 10123.835 of the Insurance Code is amended to read:10123.835. (a) A health insurance policy that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with good professional practice. nationally recognized, evidence-based clinical guidelines.(b) This section does not require a health insurance policy to cover the surgical and other procedures known as radical prostatectomy, external beam radiation therapy, radiation seed implants, and combined hormonal therapy, or to prevent application of deductible or copayment provisions contained in the policy, nor does this section require that coverage under a health insurance policy be extended to any other procedures.(c) (1) Notwithstanding subdivision (b), a health insurance policy that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an insured who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. High For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.(d) This section does not apply to specialized health insurance, specified accident, specified disease, hospital indemnity, Medicare supplement, or long-term care health insurance policies.
7875
7976 SEC. 2. Section 10123.835 of the Insurance Code is amended to read:
8077
8178 ### SEC. 2.
8279
83-10123.835. (a) A health insurance policy that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines.(b) This section does not require a health insurance policy to cover the surgical and other procedures known as radical prostatectomy, external beam radiation therapy, radiation seed implants, and combined hormonal therapy, or to prevent application of deductible or copayment provisions contained in the policy, nor does this section require that coverage under a health insurance policy be extended to any other procedures.(c) (1) Notwithstanding subdivision (b), a health insurance policy that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an insured who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.(d) This section does not apply to specialized health insurance, specified accident, specified disease, hospital indemnity, Medicare supplement, or long-term care health insurance policies.
80+10123.835. (a) A health insurance policy that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with good professional practice. nationally recognized, evidence-based clinical guidelines.(b) This section does not require a health insurance policy to cover the surgical and other procedures known as radical prostatectomy, external beam radiation therapy, radiation seed implants, and combined hormonal therapy, or to prevent application of deductible or copayment provisions contained in the policy, nor does this section require that coverage under a health insurance policy be extended to any other procedures.(c) (1) Notwithstanding subdivision (b), a health insurance policy that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an insured who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. High For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.(d) This section does not apply to specialized health insurance, specified accident, specified disease, hospital indemnity, Medicare supplement, or long-term care health insurance policies.
8481
85-10123.835. (a) A health insurance policy that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines.(b) This section does not require a health insurance policy to cover the surgical and other procedures known as radical prostatectomy, external beam radiation therapy, radiation seed implants, and combined hormonal therapy, or to prevent application of deductible or copayment provisions contained in the policy, nor does this section require that coverage under a health insurance policy be extended to any other procedures.(c) (1) Notwithstanding subdivision (b), a health insurance policy that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an insured who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.(d) This section does not apply to specialized health insurance, specified accident, specified disease, hospital indemnity, Medicare supplement, or long-term care health insurance policies.
82+10123.835. (a) A health insurance policy that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with good professional practice. nationally recognized, evidence-based clinical guidelines.(b) This section does not require a health insurance policy to cover the surgical and other procedures known as radical prostatectomy, external beam radiation therapy, radiation seed implants, and combined hormonal therapy, or to prevent application of deductible or copayment provisions contained in the policy, nor does this section require that coverage under a health insurance policy be extended to any other procedures.(c) (1) Notwithstanding subdivision (b), a health insurance policy that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an insured who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. High For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.(d) This section does not apply to specialized health insurance, specified accident, specified disease, hospital indemnity, Medicare supplement, or long-term care health insurance policies.
8683
87-10123.835. (a) A health insurance policy that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines.(b) This section does not require a health insurance policy to cover the surgical and other procedures known as radical prostatectomy, external beam radiation therapy, radiation seed implants, and combined hormonal therapy, or to prevent application of deductible or copayment provisions contained in the policy, nor does this section require that coverage under a health insurance policy be extended to any other procedures.(c) (1) Notwithstanding subdivision (b), a health insurance policy that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an insured who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.(d) This section does not apply to specialized health insurance, specified accident, specified disease, hospital indemnity, Medicare supplement, or long-term care health insurance policies.
84+10123.835. (a) A health insurance policy that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with good professional practice. nationally recognized, evidence-based clinical guidelines.(b) This section does not require a health insurance policy to cover the surgical and other procedures known as radical prostatectomy, external beam radiation therapy, radiation seed implants, and combined hormonal therapy, or to prevent application of deductible or copayment provisions contained in the policy, nor does this section require that coverage under a health insurance policy be extended to any other procedures.(c) (1) Notwithstanding subdivision (b), a health insurance policy that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an insured who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:(A) A person with a prostate who is 55 years of age or older.(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. High For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.(2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.(d) This section does not apply to specialized health insurance, specified accident, specified disease, hospital indemnity, Medicare supplement, or long-term care health insurance policies.
8885
8986
9087
91-10123.835. (a) A health insurance policy that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with nationally recognized, evidence-based clinical guidelines.
88+10123.835. (a) A health insurance policy that is issued, amended, or renewed on or after January 1, 1999, shall be deemed to provide coverage for the screening and diagnosis of prostate cancer, including prostate-specific antigen testing and digital rectal examinations, when medically necessary and consistent with good professional practice. nationally recognized, evidence-based clinical guidelines.
9289
9390 (b) This section does not require a health insurance policy to cover the surgical and other procedures known as radical prostatectomy, external beam radiation therapy, radiation seed implants, and combined hormonal therapy, or to prevent application of deductible or copayment provisions contained in the policy, nor does this section require that coverage under a health insurance policy be extended to any other procedures.
9491
9592 (c) (1) Notwithstanding subdivision (b), a health insurance policy that is issued, amended, or renewed on or after January 1, 2024, shall not apply a deductible, copayment, or coinsurance to coverage for screening services for prostate cancer described in subdivision (a) for an insured who is at a high risk of prostate cancer, consistent with nationally recognized, evidence-based clinical guidelines, and is either of the following:
9693
9794 (A) A person with a prostate who is 55 years of age or older.
9895
99-(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.
96+(B) A person with a prostate who is 40 years of age or older and who is high risk, as determined by the attending or treating health care provider. High For purposes of this subparagraph, high risk includes a person with a prostate who is Black, has a family history of prostate cancer, has a genetic predisposition to prostate cancer, or is a veteran.
10097
10198 (2) For high deductible plans, this subdivision is subject to federal guidance on the preventive care safe harbor for the absence of a preventive care deductible provided for under Section 223(c)(2)(C) of Title 26 of the United States Code.
10299
103100 (d) This section does not apply to specialized health insurance, specified accident, specified disease, hospital indemnity, Medicare supplement, or long-term care health insurance policies.
104101
105102 SEC. 3. No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
106103
107104 SEC. 3. No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
108105
109106 SEC. 3. No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
110107
111108 ### SEC. 3.